Fluoride, lead co-exposure linked to lower youth BMD
Researchers analyzed NHANES data from 2,378 U.S. children and adolescents who underwent DEXA scans from 2013 to 2016.

Combined low-dose exposure to fluoride and lead was associated with greater reductions in bone mineral density in children and adolescents than exposure to either substance alone, according to a study in Journal of Trace Elements in Medicine and Biology.
Chunxiang Li, PhD, of Zhengzhou University, and colleagues used National Health and Nutrition Examination Survey data from 2013 to 2016. The analysis included 2,378 U.S. participants ages 8 to 19 with fluoride, lead, DEXA, and covariate data.
DEXA measures included bone mineral density of the lumbar spine, pelvis, left leg, and right leg. Exposure data included plasma or water fluoride and blood or urine lead.
Plasma fluoride and water fluoride each showed U-shaped nonlinear associations with bone mineral density, according to the study. BMD decreased as fluoride increased at lower concentrations, with inflection points of about 0.37 µmol/L in plasma and 0.37 mg/L in drinking water.
Lead exposure showed a sharper BMD decline at lower exposure levels, followed by a slower decrease at higher levels. Higher lead levels were associated with lower BMD in the pelvis and legs.
Interaction modeling found that each 1-unit increase in the plasma fluoride and blood lead interaction term was associated with BMD decreases of 1.679 in the lumbar spine, 3.104 in the left leg, and 3.068 in the right leg.
“Co-exposure to fluoride and lead has a more pronounced effect on BMD than exposure to either substance alone,” the authors wrote.
The study is titled “Low-Dose Fluoride and Lead Co-Exposure Alters Bone Mineral Density in Youth: A Nationally Representative Cross-Sectional Study.” Its DOI is 10.1016/j.jtemb.2026.127889.
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section

Quantum reports early results from MS PET study
The ongoing MGH study is evaluating [18F]3F4AP PET imaging for demyelinated neurons with intact axons in patients with multiple sclerosis.

Cochrane updates prostate cancer screening review
The updated review found PSA screening likely reduces prostate cancer deaths, but evidence remains unclear for newer screening strategies combining PSA, kallikrein testing, and MRI.

Stage 4 breast cancer diagnoses rise over decade
A cohort study of 761,471 people found de novo stage 4 breast cancer incidence increased by 1.2% per year from 2010 to 2021.